A Randomized, Open-Label, Two-Way Crossover Study to Determine the Effects of Co-Administration of AZD7325 and a Monophasic Oral Contraceptive Containing Ethinyl Estradiol and Norgestimate in Healthy Female Subjects.

Trial Profile

A Randomized, Open-Label, Two-Way Crossover Study to Determine the Effects of Co-Administration of AZD7325 and a Monophasic Oral Contraceptive Containing Ethinyl Estradiol and Norgestimate in Healthy Female Subjects.

Suspended
Phase of Trial: Phase I

Latest Information Update: 09 Dec 2009

At a glance

  • Drugs AZD 7325; Ethinylestradiol/norgestimate
  • Indications Anxiety; Pregnancy
  • Focus Pharmacokinetics
  • Sponsors AstraZeneca
  • Most Recent Events

    • 30 Oct 2009 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.
    • 19 May 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top